biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > How Profound!

<< Previous

Bullboard Posts

Next >>

Comment by JDavenporton Jul 28, 2022 12:41pm

175 Views

Post# 34857377

RE:RE:RE:RE:RE:RE:RE:How Profound!

Thanks, Aarcor. I'm off for a 7k walk and coffee with Da Boyz. Fewer birds now. Breeding season is over, I think. Took down the hummingbird feeders yesterday. Had a great dump this morning, on schedule.

Going to be 38° or so, here, today. Hotter than a snake's a$$ in a wagon rut.

Enjoy your angry day, bud.

jd

<< Previous

Bullboard Posts

Next >>

Unique Battery Metals opportunity in Quebec